B
Beryl Drugs
20.50
BSE
B
Beryl Drugs
20.50
BSE
BERLDRG Fundamentals
Company Valuation
Market Cap (₹ Cr.)
10
PE Ratio
683.30
PB Ratio
1.10
Dividend Yield
-
ROE
6.09%
ROCE
11.97%
Book Value (₹)
18.63
Face Value (₹)
10.00
Analyse BERLDRG with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 26.38% | 26.38% | 26.38% | 26.38% | 27.48% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 68.53% | 68.69% | 68.71% | 66.25% | 64.94% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BERLDRG Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524606
NSE Scrip Name
BERLDRG
ISIN
INE415H01017



